TABLE 2

HPV Vaccination Coverage Among Girls 13 to 17 Years of Age, According to Sociodemographic Characteristics

Sociodemographic Characteristic≥1 Dose of HPV Vaccine≥3 Doses of HPV Vaccine Among Those Who Initiated Series
Unadjusted Coverage Rate, % Estimate (95% CI)Prevalence RatioaUnadjusted Coverage Rate, % Estimate (95% CI)Prevalence Ratioa
Total40.5 (39.2–41.9)53.3 (51.1–55.6)
Year
    200837.0 (34.9–39.1)b0.9 (0.8–1.0)46.8 (43.3–0.4)b0.8 (0.7–0.8)
    200944.1 (42.3–46.0)cReference58.9 (55.9–1.7)cReference
Age
    13 y36.0 (33.2–38.9)cReference45.8 (41.1–50.7)cReference
    14 y37.1 (34.2–40.1)1.1 (1.0–1.2)52.1 (47.3–56.8)1.1 (1.0–1.2)
    15 y43.9 (40.8–47.1)b1.2 (1.1–1.4)49.1 (44.2–54.0)1.0 (0.9–1.2)
    16 y42.9 (39.8–46.1)b1.3 (1.1–1.5)59.5 (54.4–64.3)b1.2 (1.0–1.4)
    17 y42.3 (38.9–45.7)b1.2 (1.1–1.4)59.0 (53.5–64.2)b1.1 (0.9–1.4)
Race
    White, non-Hispanic39.3 (37.7–40.8)cReference60.4 (57.8–63.0)cReference
    Black, non-Hispanic40.1 (36.1–44.2)1.0 (0.9–1.1)46.0 (39.1–53.0)b0.9 (0.8–1.0)
    Hispanic44.5 (40.4–48.7)b1.1 (1.0–1.2)40.3 (34.8–46.0)b0.8 (0.7–1.0)
    American Indian/Alaskan Native52.6 (41.4–63.5)b1.2 (1.0–1.6)47.1 (32.0–62.7)1.0 (0.8–1.3)
    Asian41.1 (32.1–50.8)1.0 (0.9–1.2)43.9 (30.0–59.0)b0.8 (0.6–1.2)
    Other40.9 (32.7–49.6)0.9 (0.7–1.2)48.5 (36.1–61.1)0.9 (0.7–1.2)
Income level
    <133% of FPL44.9 (41.6–48.3)1.1 (0.9–1.2)44.1 (39.0–49.4)b1.0 (0.9–1.2)
    133% to <322% of FPL34.8 (32.5–37.2)b0.9 (0.8–1.0)49.4 (45.2–53.6)b0.9 (0.8–1.0)
    322% to <503% of FPL39.6 (37.1–42.1)b0.9 (0.9–1.0)62.4 (58.5–66.2)1.1 (1.0–1.2)
    >503% of FPL44.7 (41.8–47.6)cReference60.0 (55.6–64.2)cReference
Mother's education
    Less than high school42.1 (37.7–46.6)1.0 (0.9–1.2)38.6 (32.4–45.2)b0.9 (0.8–1.1)
    High school39.0 (35.9–42.2)1.0 (0.9–1.1)49.3 (44.0–54.7)b0.9 (0.8–1.0)
    More than high school, some college39.9 (37.5–42.3)1.0 (1.0–1.1)54.0 (50.0–58.0)b1.0 (0.9–1.1)
    College graduate41.7 (39.7–43.7)cReference62.0 (59.1–64.9)cReference
Mother's marital status
    Married39.3 (37.8–40.9)cReference56.2 (53.6–58.7)cReference
    Divorced/widowed/separated41.8 (38.4–45.4)1.1 (1.0–1.2)48.5 (43.1–54.0)b0.9 (0.8–1.0)
    Never married47.7 (42.2–53.2)b1.2 (1.0–1.3)38.1 (31.0–45.7)b0.9 (0.7–1.1)
Mother's age
    ≤34 y45.6 (40.6–50.7)cReference36.0 (29.2–43.3)cReference
    35–44 y39.2 (37.1–41.5)b0.8 (0.8–0.9)51.2 (47.5–54.8)b1.2 (1.0–1.4)
    ≥45 y40.9 (39.1–42.8)0.8 (0.7–0.9)59.2 (56.2–62.2)b1.2 (1.0–1.5)
MSA
    Urban43.0 (40.6–45.4)cReference49.7 (46.0–53.3)cReference
    Suburban41.3 (39.2–43.5)1.0 (0.9–1.1)55.9 (52.3–59.4)b1.1 (1.0–1.2)
    Rural32.8 (30.4–35.2)b0.9 (0.9–1.0)55.4 (51.0–59.7)b1.1 (1.0–1.2)
Had 11- to 12-y preventive care visit
    Yes48.8 (46.1–51.5)cReference54.6 (50.8–58.4)cReference
    No31.2 (28.9–33.6)b0.8 (0.7–0.9)45.6 (41.2–50.0)b0.9 (0.8–1.0)
    HPV vaccine not licensed when 11 or 12 y of aged41.9 (39.7–44.0)b0.9 (0.8–1.0)55.9 (52.4–59.3)1.0 (0.9–1.1)
Insurance status
    Private39.0 (37.4–40.7)cReference57.9 (55.0–60.7)cReference
    VFC-eligible, all others47.3 (44.2–50.5)b1.2 (1.1–1.3)44.9 (40.3–49.7)b1.0 (0.9–1.1)
    VFC eligible, uninsured only23.7 (19.3–28.8)b0.9 (0.7–1.1)43.7 (33.7–54.2)b1.0 (0.8–1.2)
    SCHIP52.4 (44.2–60.5)b1.2 (1.0–1.5)52.5 (41.3–63.4)1.2 (1.0–1.4)
    Military35.1 (27.2–43.8)0.8 (0.6–1.1)57.3 (43.4–70.2)1.0 (0.8–1.3)
    Other34.8 (21.8–50.6)0.7 (0.4–1.2)53.1 (31.5–73.6)0.8 (0.5–1.3)
Know of HPV
    Yes41.9 (40.6–43.4)cReference55.3 (53.1–57.5)cReference
    No25.2 (18.8–32.9)b1.0 (0.8–1.2)20.2 (12.7–30.7)b0.6 (0.4–0.9)
Heard of HPV vaccine
    Yes41.8 (40.3–43.2)cReference55.1 (52.9–57.4)cReference
    No33.7 (29.2–38.5)b1.0 (0.9–1.1)43.2 (34.3–52.5)b0.9 (0.8–1.1)
Received provider recommendation for vaccinee
    Yes58.3 (56.5–60.2)b2.6 (2.4–2.9)56.9 (54.3–59.3)b1.1 (1.0–1.2)
    No20.7 (18.9–22.7)cReference43.4 (38.4–48.4)cReference
Facility types for adolescent's vaccination providers
    All private facilities44.7 (42.8–46.6)cReference56.2 (53.2–59.1)cReference
    All public facilities26.5 (23.9–29.2)b0.7 (0.6–0.8)38.9 (33.8–44.2)b0.8 (0.7–0.9)
    All hospital facilities44.8 (40.1–49.5)1.0 (0.9–1.1)53.9 (46.7–60.9)1.0 (0.9–1.1)
    All STD/school/teen clinics or other facilities38.8 (31.0–47.2)1.0 (0.8–1.2)52.6 (38.9–65.9)1.0 (0.8–1.3)
    Mixed42.4 (38.1–46.9)1.0 (0.9–1.1)54.6 (47.2–61.8)0.9 (0.8–1.1)
    Unknown35.9 (29.7–42.7)b0.9 (0.8–1.0)47.1 (37.1–57.2)0.9 (0.7–1.0)
  • STD indicates sexually transmitted disease.

  • a Logistic regression models were adjusted for survey year and state of residence.

  • b P ≤ .05.

  • c Reference level.

  • d Girls who were older than 12 years of age at the time of HPV vaccine licensure (June 8, 2006) and did not have the opportunity to receive HPV vaccine at an 11- to 12-year preventive visit.

  • e Parents reported whether they had received a recommendation for their daughters to receive HPV vaccinations from a health care provider.